Microarray analysis of breast cancer gene expression profiling in response to 2-deoxyglucose, metformin, and glucose starvation
Abstract Background Breast cancer (BC) is the most frequently diagnosed cancer in women. Altering glucose metabolism and its effects on cancer progression and treatment resistance is an emerging interest in BC research. For instance, combining chemotherapy with glucose-lowering drugs (2-deoxyglucose...
Main Authors: | Rita Aoun, Christopher El Hadi, Roula Tahtouh, Rita El Habre, George Hilal |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-03-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-022-02542-w |
Similar Items
-
Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy
by: Samson Mathews Samuel, et al.
Published: (2023-08-01) -
High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells
by: Sharon Varghese, et al.
Published: (2019-01-01) -
Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming
by: Ioannis S. Pateras, et al.
Published: (2023-03-01) -
Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01) -
Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population
by: Moses Galukande, et al.
Published: (2014-04-01)